Skip to main content

Envoy Medical, Inc.

corporate_fare Company Profile

Envoy Medical, Inc.

COCH·NASDAQ·Life Sciences·CIK 0001840877

Envoy Medical, Inc. is a hearing health company that develops innovative medical technologies for various types of hearing loss. The company aims to provide hearing devices that leverage the ear's natural anatomy, specifically by using an implanted sensor to capture sound energy from the ossicular chain (the three small hearing bones connecting the eardrum to the cochlea). This sensor converts mechanical energy into a signal that can be processed and amplified to meet a patient's specific hearing needs. Envoy Medical's initial product, the Esteem FI-AMEI, received FDA approval in 2010. It is the only FDA-approved fully implanted active hearing implant available. Despite its unique status, the Esteem FI-AMEI faced commercial challenges, primarily because the Centers for Medicaid and Medicare Services (CMS) classified it as a hearing aid, which limited coverage eligibility. The company continues to seek proper classification for the Esteem FI-AMEI as a Fully Implanted Active Middle Ear Implant. Globally, approximately 1,000 Esteem FI-AMEI devices have been implanted, including some during clinical trials in the early 2000s. This has provided Envoy Medical with over two decades of experience with its implantable sensor technology, which has demonstrated itself as a viable alternative to external or implanted microphones.

Envoy Medical, Inc. (NASDAQ:COCH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for COCH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for COCH spans 8-K, DEF 14A, PRE 14A, 10-Q.

Recent high-impact activity:

  • Envoy Medical Beats Q3 Loss Estimates at $0.50/Share, Revenue Up 57%
  • Envoy Medical Q3 Loss Narrows to $5.2M; Cash $14.6M as PMA Module Two Filed
  • Envoy Medical Sets October 12 Vote on 1-for-5 to 1-for-25 Reverse Split to Avoid Nasdaq Delisting
  • Envoy Medical Seeks Shareholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
  • Envoy Medical Reports Q2 2026 Results, Submits First PMA Module to FDA, and Posts Positive 12-Month Trial Data

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$241K
Net Income
-$23.76M
Diluted EPS
-$1.23
Op. Cash Flow
-$18.2M
Free Cash Flow
-$18.38M
Gross Profit
-$633K
Operating Income
-$22.27M
Cash & Equivalents
$3.74M
Debt / Equity
0.00×
Net Margin
-98.57×
Shares Outstanding
23.26M sh
Source: 10-K · filed 2026-04-13 · accession 0001213900-26-043011

Short Interest & Short Volume

2.67 days to cover

FINRA reported short interest of 89,915 shares in COCH as of the October 30, 2026 settlement, a 84.4% decrease from the prior period — about 2.7 days to cover at its recent average daily volume. On November 13, 2026, 34.2% of COCH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)89,915 shares as of October 30, 2026
Change vs prior period▼ 84.4%
Days to cover2.67 at avg daily volume of 33,639
Daily short volume (FINRA facilities)34.2% of 7,277 shares on November 13, 2026
5-day average short volume31.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$6.74
52-week range · as of 2026-11-05 $3.63 – $9.54
Market cap
$52.13M
Volume
10K (0.4× avg)
3-mo avg 25.4K
Live data · 2026-11-16 03:57 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed COCH - Latest Insights

COCH
Nov 05, 2026, 1:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $6.74 info
Change: -$0.310 (-4%) info
Market Cap: $52.125M info
COCH
Nov 05, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $6.74 info
Change: -$0.385 (-5%) info
Market Cap: $52.125M info
COCH
Aug 31, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Aug 19, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Aug 10, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.705
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Aug 10, 2026, 8:31 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.6932
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Jul 21, 2026, 9:17 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.706
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Jul 14, 2026, 9:17 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.737
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Jun 25, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.6711
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Jun 25, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6711
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Jun 25, 2026, 8:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.6537
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
May 22, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.690
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
May 20, 2026, 8:30 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.7252
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
May 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7136
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
May 11, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.630
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
May 11, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.648
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Apr 21, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.715
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Apr 02, 2026, 4:01 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.7475
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Apr 01, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.687
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
COCH
Mar 31, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6651
Real-time Price: $6.74 info
Change: Reverse Stock Split info
Market Cap: $52.125M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets